RCM
LVACW

Radcliffe Capital Management’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Radcliffe Capital Management’s Portfolio LVACW Stock Details LVACW Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$5.84K Hold
2022
Q4 		$714K Hold
2022
Q3 		$700K Buy
2022
Q2 		$517K Hold
2022
Q1 		$517K Buy
2021
Q4 		$500K Buy